Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Utility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis.
Tiwari A, Alcover K, Carpenter E, Thomas K, Krum J, Nissen A, Van Decar S, Smolinsky T, Valdera F, Vreeland T, Lacher M, Del Priore G, Williams W, Stojadinovic A, Peoples G, Clifton G. Tiwari A, et al. Among authors: smolinsky t. Hum Vaccin Immunother. 2024 Dec 31;20(1):2323256. doi: 10.1080/21645515.2024.2323256. Epub 2024 Mar 27. Hum Vaccin Immunother. 2024. PMID: 38544385 Free PMC article.
Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention.
O'Shea AE, Valdera FA, Ensley D, Smolinsky TR, Cindass JL, Kemp Bohan PM, Hickerson AT, Carpenter EL, McCarthy PM, Adams AM, Vreeland TJ, Clifton GT, Peoples GE. O'Shea AE, et al. Among authors: smolinsky tr. Clin Immunol. 2022 Dec;245:109095. doi: 10.1016/j.clim.2022.109095. Epub 2022 Aug 13. Clin Immunol. 2022. PMID: 35973640 Review.
Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials.
McCarthy PM, Valdera FA, Smolinsky TR, Adams AM, O'Shea AE, Thomas KK, Van Decar S, Carpenter EL, Tiwari A, Myers JW, Hale DF, Vreeland TJ, Peoples GE, Stojadinovic A, Clifton GT. McCarthy PM, et al. Among authors: smolinsky tr. Front Immunol. 2023 Mar 7;14:1090533. doi: 10.3389/fimmu.2023.1090533. eCollection 2023. Front Immunol. 2023. PMID: 36960052 Free PMC article.
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis.
Carpenter EL, Van Decar S, Adams AM, O'Shea AE, McCarthy P, Chick RC, Clifton GT, Vreeland T, Valdera FA, Tiwari A, Hale D, Kemp Bohan P, Hickerson A, Smolinsky T, Thomas K, Cindass J, Hyngstrom J, Berger AC, Jakub J, Sussman JJ, Shaheen MF, Yu X, Wagner TE, Faries M, Peoples GE. Carpenter EL, et al. Among authors: smolinsky t. J Immunother Cancer. 2023 Aug;11(8):e006665. doi: 10.1136/jitc-2023-006665. J Immunother Cancer. 2023. PMID: 37536936 Free PMC article. Clinical Trial.
Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters.
Valdera FA, O'Shea AE, Smolinsky TR, Carpenter EL, Adams AA, McCarthy PM, Tiwari A, Chick RC, Kemp-Bohan PM, Van Decar S, Thomas KK, Bader JO, Peoples GE, Clifton GT, Stojadinovic A, Nelson DW, Vreeland TJ. Valdera FA, et al. Among authors: smolinsky tr. J Surg Oncol. 2024 Feb;129(2):244-253. doi: 10.1002/jso.27466. Epub 2023 Oct 6. J Surg Oncol. 2024. PMID: 37800378
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy.
Carpenter EL, Van Decar SG, McCarthy PM, Valdera FA, Adams AM, O'Shea AE, Smolinsky T, Thomas K, Clifton GT, Newhook TE, Peoples GE, Nelson DW, Vreeland TJ. Carpenter EL, et al. Among authors: smolinsky t. J Surg Oncol. 2024 May 27. doi: 10.1002/jso.27689. Online ahead of print. J Surg Oncol. 2024. PMID: 38801055
13 results